Total Payments
$17,288
2020 Payments
$7,563
Companies
5
Transactions
45
Medicare Patients
1,032
Medicare Billing
$96,266
Payment Breakdown by Category
Other$16,563 (95.8%)
Food & Beverage$419.39 (2.4%)
Travel$305.35 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,563 | 19 | 95.8% |
| Food and Beverage | $419.39 | 21 | 2.4% |
| Travel and Lodging | $305.35 | 5 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $17,121 | 41 | $0 (2020) |
| Amgen Inc. | $96.26 | 1 | $0 (2018) |
| Intuitive Surgical, Inc. | $46.13 | 1 | $0 (2019) |
| Acorda Therapeutics, Inc | $13.20 | 1 | $0 (2018) |
| Biogen, Inc. | $11.84 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $7,563 | 11 | Allergan, Inc. ($7,563) |
| 2019 | $46.13 | 1 | Intuitive Surgical, Inc. ($46.13) |
| 2018 | $109.46 | 2 | Amgen Inc. ($96.26) |
| 2017 | $9,569 | 31 | Allergan Inc. ($9,557) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $46.13 | General |
| Category: SURGERY | ||||||
| 05/09/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13.20 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 04/24/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $96.26 | General |
| 08/22/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2017 | Allergan Inc. | NAMZARIC (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: NEUROLOGY | ||||||
| 06/16/2017 | Allergan Inc. | NAMZARIC (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Travel and Lodging | In-kind items and services | $92.02 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 10 | 1,032 | 1,296 | $308,977 | $96,266 |
Total Patients
1,032
Total Services
1,296
Medicare Billing
$96,266
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 289 | 328 | $67,896 | $26,342 | 38.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 114 | 114 | $39,102 | $12,942 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 157 | 191 | $25,212 | $10,420 | 41.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 113 | 209 | $50,369 | $10,277 | 20.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 90 | 166 | $23,074 | $9,842 | 42.7% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 61 | 61 | $37,576 | $8,278 | 22.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 54 | 54 | $27,540 | $5,639 | 20.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 36 | $10,116 | $4,124 | 40.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 47 | 47 | $11,374 | $3,360 | 29.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 23 | 23 | $7,889 | $2,116 | 26.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 29 | 45 | $4,275 | $1,513 | 35.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 22 | $4,554 | $1,411 | 31.0% |
About Dr. Daniel Cacioppo, MD
Dr. Daniel Cacioppo, MD is a Neurology healthcare provider based in Buffalo Grove, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083662613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Cacioppo, MD has received a total of $17,288 in payments from pharmaceutical and medical device companies, with $7,563 received in 2020. These payments were reported across 45 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,563).
As a Medicare-enrolled provider, Cacioppo has provided services to 1,032 Medicare beneficiaries, totaling 1,296 services with total Medicare billing of $96,266. Data is available for 1 year (2020–2020), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Buffalo Grove, IL
- Active Since 05/05/2006
- Last Updated 10/05/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1083662613
Products in Payments
- NAMZARIC (Drug) $9,377
- UBRELVY (Drug) $7,563
- VRAYLAR (Drug) $179.89
- Da Vinci Surgical System (Device) $46.13
- AMPYRA (Drug) $13.20
- TYSABRI (Biological) $11.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.